Influence of interferon-α and ribavirin on the transcription of interferon-γ and IFN-γ receptor genes in Jurkat cells

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 3, 2008, Pages 345-351

  Sypniewski, Daniel ^a   Bednarek, Ilona ^a   Gałka, Sabina ^a   Loch, Tomasz ^a   Machnik, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Chronic hepatitis C; HCV; IFN receptor; Iinterferon ; Interferon ; Jurkat cells; Real time RT PCR; Ribavirin

Indexed keywords

ALPHA INTERFERON; DEXAVEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 1; GAMMA INTERFERON RECEPTOR 2; MESSENGER RNA; RIBAVIRIN;

ANTIVIRAL ACTIVITY; ARTICLE; CHRONIC HEPATITIS; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATITIS C; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIVIRAL AGENTS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; JURKAT CELLS; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 45849107948     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bell H., Hellum K., Harthug S., Myrvang B. et al.: Scand. J. Gastroenterol. 2, 194 (1999).
2. Poynard T., Marcellin P., Lee S.S. et al.: Lancet 352, 1426 (1998).
3. Buckwold V.E.: J. Antimicrob. Chemother. 53, 413 (2004).
4. Buckwold V.E., Wei J., Wenzel-Mathers M., Russell J.: Antimicrob. Agents Chemother. 47, 2293 (2003).
5. De Francesco R., Migliaccio G.: Nature 436, 953 (2005).
6. Barnes E., Harcourt G., Brown D., Lucas M., Phillips R., Dusheiko G., Klenerman P.: Hepatology 36, 743 (2002).
7. Martin J., Navas S., Quiroga J.A., Pardo M., Carreno V.: Cytokine 10, 635 (1998).
8. Tam R.C., Pai B., Bard J., Lim C., Averett D.R., Phan U.T., Milovanovic T.: J. Hepatol. 30, 376 (1999).
9. Bach E.A., Aguet M., Schreiber R.D.: Annu. Rev. Immunol. 15, 563 (1997).
10. Boehm U., Klamp T., Groot M., Howard J.C.: Annu. Rev. Immunol. 15, 749 (1997).
11. Goodbourn S., Didcock L., Randall R.E.: J. Gen. Virol. 81, 2341 (2000).
12. Kawakami Y., Nabeshima S., Furusyo N., Sawayama Y., Hayashi J., Kashiwagi S.: Am. J. Gastroenterol. 95, 227 (2000).
13. Iwata K., Wakita T., Okumura A., Yoshioka K., Takayanagi M., Wands J.R., Kakumu S.: Hepatology 22, 1057 (1995).
14. Schirren C., Jung M., Gerlach J. et al.: Hepatology 32, 597 (2000).
15. Baroni G.S., Pastorelli A., Manzin A. et al.: Liver 19, 212 (1999).
16. Napoli J., Bishop G., McGuinness P., Painter D., McCaughan G.: Hepatology 24, 759 (1996).
17. Bergamini A., Bolacchi F., Cepparulo M. et al.: Clin. Exp. Immunol. 123, 459 (2001).
18. Barnes E., Salio M., Cerundolo V., Medlin J., Murphy S., Dusheiko G., Klenerman P.: Antimicrob. Agents Chemother. 48, 3382 (2004).
19. Shiffman M.L., Verbeke S.B., Kimball P.M.: Antiviral Res. 48, 91 (2000).
20. Hultgren C., Milich D.R., Weiland O., Sallberg M.: J. Gen. Virol.: 79, 2381 (1998).
21. Martin J., Navas S., Quiroga J.A., Pardo M., Carreno V.: Cytokine 10, 635 (1998).
22. Ning Q., Brown D., Parodo J., Cattral M. et al.: J. Immunol. 160, 3487 (1998).
23. Zhang Y., Jamaluddin M., Wang S., Tian B., Garofalo R.P., Casola A., Brasier A.R.: J. Virol. 77, 5933 (2003).
24. Larrea E., Aldabe R., Molano E., Fernandez-Rodriguez C.M., Ametzazurra A., Civeira M.P., Prieto J.: Gut 55, 1188 (2006).